Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Network analysis identifies an HSP90-central hub susceptible in ovarian cancer.
Liu H, Xiao F, Serebriiskii IG, O'Brien SW, Maglaty MA, Astsaturov I, Litwin S, Martin LP, Proia DA, Golemis EA, Connolly DC. Liu H, et al. Among authors: astsaturov i. Clin Cancer Res. 2013 Sep 15;19(18):5053-67. doi: 10.1158/1078-0432.CCR-13-1115. Epub 2013 Jul 30. Clin Cancer Res. 2013. PMID: 23900136 Free PMC article.
Selective Raf inhibition in cancer therapy.
Khazak V, Astsaturov I, Serebriiskii IG, Golemis EA. Khazak V, et al. Among authors: astsaturov i. Expert Opin Ther Targets. 2007 Dec;11(12):1587-609. doi: 10.1517/14728222.11.12.1587. Expert Opin Ther Targets. 2007. PMID: 18020980 Free PMC article. Review.
Mechanisms of tumor resistance to EGFR-targeted therapies.
Hopper-Borge EA, Nasto RE, Ratushny V, Weiner LM, Golemis EA, Astsaturov I. Hopper-Borge EA, et al. Among authors: astsaturov i. Expert Opin Ther Targets. 2009 Mar;13(3):339-62. doi: 10.1517/14712590902735795. Expert Opin Ther Targets. 2009. PMID: 19236156 Free PMC article. Review.
Targeting EGFR resistance networks in head and neck cancer.
Ratushny V, Astsaturov I, Burtness BA, Golemis EA, Silverman JS. Ratushny V, et al. Among authors: astsaturov i. Cell Signal. 2009 Aug;21(8):1255-68. doi: 10.1016/j.cellsig.2009.02.021. Epub 2009 Mar 1. Cell Signal. 2009. PMID: 19258037 Free PMC article. Review.
Synthetic lethal screen of an EGFR-centered network to improve targeted therapies.
Astsaturov I, Ratushny V, Sukhanova A, Einarson MB, Bagnyukova T, Zhou Y, Devarajan K, Silverman JS, Tikhmyanova N, Skobeleva N, Pecherskaya A, Nasto RE, Sharma C, Jablonski SA, Serebriiskii IG, Weiner LM, Golemis EA. Astsaturov I, et al. Sci Signal. 2010 Sep 21;3(140):ra67. doi: 10.1126/scisignal.2001083. Sci Signal. 2010. PMID: 20858866 Free PMC article.
Aurora A kinase (AURKA) in normal and pathological cell division.
Nikonova AS, Astsaturov I, Serebriiskii IG, Dunbrack RL Jr, Golemis EA. Nikonova AS, et al. Among authors: astsaturov i. Cell Mol Life Sci. 2013 Feb;70(4):661-87. doi: 10.1007/s00018-012-1073-7. Epub 2012 Aug 3. Cell Mol Life Sci. 2013. PMID: 22864622 Free PMC article. Review.
Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation.
Sukhanova A, Gorin A, Serebriiskii IG, Gabitova L, Zheng H, Restifo D, Egleston BL, Cunningham D, Bagnyukova T, Liu H, Nikonova A, Adams GP, Zhou Y, Yang DH, Mehra R, Burtness B, Cai KQ, Klein-Szanto A, Kratz LE, Kelley RI, Weiner LM, Herman GE, Golemis EA, Astsaturov I. Sukhanova A, et al. Among authors: astsaturov i. Cancer Discov. 2013 Jan;3(1):96-111. doi: 10.1158/2159-8290.CD-12-0031. Epub 2012 Nov 2. Cancer Discov. 2013. PMID: 23125191 Free PMC article.
75 results